Literature DB >> 6423098

Hypertrophic osteoarthropathy in cystic fibrosis.

S Braude, H Kennedy, M Hodson, J Batten.   

Abstract

Seven adult patients with cystic fibrosis who had radiological evidence of hypertrophic osteoarthropathy were reviewed. In five of the patients symptoms were particularly pronounced at times of acute infective exacerbations; appropriate treatment of the infective episodes resulted in reduction or resolution of the bone pain and joint effusions. Despite this symptomatic relief periosteal changes persisted radiologically and their chronic nature was indicated by changes in the midshafts of long bones. Four of the seven patients had transient gynaecomastia or mastalgia related to infective exacerbations. It is hypothesised that a neuroendocrine mechanism--namely, release of vasoactive intestinal polypeptide--might account for the osteoarthropathy.

Entities:  

Mesh:

Year:  1984        PMID: 6423098      PMCID: PMC1441581          DOI: 10.1136/bmj.288.6420.822

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  12 in total

1.  HYPERTROPHIC OSTEOARTHROPATHY IN CYSTIC FIBROSIS.

Authors:  H GROSSMAN; C R DENNING; D H BAKER
Journal:  Am J Dis Child       Date:  1964-01

2.  Observations on the peripheral circulation in hypertrophic pulmonary osteoarthropathy.

Authors:  J GINSBURG
Journal:  Q J Med       Date:  1958-07

3.  Detection of hypertrophic pulmonary osteoarthropathy of skeletal imaging with 99mTc-labeled diphosphonate.

Authors:  B Donnelly; P M Johnson
Journal:  Radiology       Date:  1975-02       Impact factor: 11.105

4.  The effect of adrenergic blockade in hypertrophic pulmonary osteoarthropathy (HPOA).

Authors:  G Reardon; A J Collins; P A Bacon
Journal:  Postgrad Med J       Date:  1976-03       Impact factor: 2.401

5.  Episodic arthritis in children with cystic fibrosis.

Authors:  A J Newman; B M Ansell
Journal:  J Pediatr       Date:  1979-04       Impact factor: 4.406

Review 6.  Gynecomastia.

Authors:  H E Carlson
Journal:  N Engl J Med       Date:  1980-10-02       Impact factor: 91.245

Review 7.  Digital clubbing and hypertrophic osteoarthropathy: The underlying mechanisms.

Authors:  J M Shneerson
Journal:  Br J Dis Chest       Date:  1981-04

8.  Vasoactive intestinal polypeptide is more potent than prostaglandin E2 as a vasodilator and oedema potentiator in rabbit skin.

Authors:  T J Williams
Journal:  Br J Pharmacol       Date:  1982-11       Impact factor: 8.739

9.  Hypertrophic osteoarthropathy in adults with cystic fibrosis.

Authors:  M A Matthay; R A Matthay; D M Mills; S Lakshminarayan; E Cotton
Journal:  Thorax       Date:  1976-10       Impact factor: 9.139

10.  Pulmonary hypertrophic osteoarthropathy in cystic fibrosis.

Authors:  I Nathanson; M M Riddlesberger
Journal:  Radiology       Date:  1980-06       Impact factor: 11.105

View more
  6 in total

1.  Unreviewed reports.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-19

2.  Rheumatoid factors in cystic fibrosis: associations with disease manifestations and recurrent bacterial infections.

Authors:  M Coffey; J Hassan; C Feighery; M Fitzgerald; B Bresnihan
Journal:  Clin Exp Immunol       Date:  1989-07       Impact factor: 4.330

Review 3.  Pathogenesis and management of arthropathy in cystic fibrosis.

Authors:  B M Phillips; T J David
Journal:  J R Soc Med       Date:  1986       Impact factor: 5.344

4.  Hypertrophic osteoarthropathy: endothelium and platelet function.

Authors:  F Silveri; R De Angelis; F Argentati; D Brecciaroli; S Muti; C Cervini
Journal:  Clin Rheumatol       Date:  1996-09       Impact factor: 2.980

5.  Hypertrophic pulmonary osteoarthropathy in cystic fibrosis.

Authors:  A M Crawford; H R Rabin; M J Fritzler
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

Review 6.  Review of current therapies for secondary hypertrophic pulmonary osteoarthropathy.

Authors:  Sheila Nguyen; Mehrnaz Hojjati
Journal:  Clin Rheumatol       Date:  2010-10-09       Impact factor: 2.980

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.